𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease

✍ Scribed by Lisa A. Maier; Lori A. Kittle; Margaret M. Mroz; Lee S. Newman

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
133 KB
Volume
43
Category
Article
ISSN
0271-3586

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum neopterin in chronic beryllium dis
Serum neopterin in chronic beryllium disease
✍ James Harris; Becki Bucher Bartelson; Elizabeth Barker; Ronald Balkissoon; Kathl πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 55 KB

We evaluated serum neopterin as a biomarker of chronic beryllium disease (CBD), for use in conjunction with the beryllium lymphocyte proliferation test (BeLPT) in workplace screening. Serum neopterin levels were determined by radioimmunoassay, and we compared levels in three groups: CBD (n 5 86), be

Racial differences in prevalence of a su
Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease
✍ Ainsley Weston; James Ensey; Kathleen Kreiss; Channa Keshava; Erin McCanlies πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 2 views

## Abstract ## Background A beryllium materials manufacturer is conducting a limited pilot program that offers testing for HLA‐DPΞ²1^E69^ with genetic counseling through a third party to applicants for employment. An important consideration in this regard is the prevalence of this marker in the gen